NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Spatially Fractionated Radiotherapy for Tumor Treatment

NCT07774819

RecruitingPhase 1, Phase 2

Sponsor: Xu Zhi-yuan

Conditions: Radiotherapy-Induced Immune Priming

Interventions: spatially fractionated radiotherapy

Countries: China

To explore the efficacy and toxicity of spatially fractionated radiotherapy in the treatment of tumors.

Eligibility overview

Sex: ALL

Age: 18 Years to 75 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Patients with a bulky solid tumor with a maximum diameter \>4 cm or a refractory solid tumor.

Exclusion Criteria:

* Tumors involving hollow viscera that are considered to have a clinically significant risk of bleeding or perforation.
* Patients with impaired consciousness or who are unable to care for themselves.

Locations (1)

Shenzhen, Guangdong, China